<DOC>
	<DOC>NCT01199406</DOC>
	<brief_summary>To determine the effect of combined intracutaneous infiltration and intraperitoneal instillation of 80 mL 0,125% levobupivacaine prior to the start of laparoscopic cholecystectomy on abdominal pain up to 24 hours after surgery.</brief_summary>
	<brief_title>Pain Reduction After Cholecystectomy</brief_title>
	<detailed_description>The primary endpoint of this study was postoperative abdominal pain as measured by a visual analogue scale (VAS), using a VAS lineal with a slide. The patient was asked to indicate a score from 0 to 100 corresponding to his or her pain. At 0.5, 2, 4, 8 and 24 hours after the surgical procedure the primary investigator visited the patient to obtain the VAS scores.</detailed_description>
	<mesh_term>Pain, Postoperative</mesh_term>
	<mesh_term>Cholecystolithiasis</mesh_term>
	<mesh_term>Cholelithiasis</mesh_term>
	<mesh_term>Gallstones</mesh_term>
	<mesh_term>Levobupivacaine</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>between 18 and 80 ASA I or II with symptomatic gallstone disease which requires elective laparoscopic cholecystectomy acute cholecystitis, cholangitis, severe acute pancreatitis, advanced liver cirrhosis or suspected gallbladder cancer, a medical history of epilepsy, cardiac arrhythmias or chronic pain of any kind, allergy to amid type drugs pregnancy patients suffering from hypotension or hypovolemia infectious liver disease conditions obstructing adequate pain scoring patients using drugs that deduce function of the CYP3A4 or CYP1A2 system patients having an American Society of Anaesthesiologists (ASA) classification of three or higher.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>gallstone</keyword>
	<keyword>gallbladder</keyword>
	<keyword>cholecystectomy</keyword>
	<keyword>laparoscopic</keyword>
	<keyword>pain</keyword>
</DOC>